Member Spotlight

Bold Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel cancer therapies. Bold Therapeutics’ lead asset, BOLD-100, is a novel Cancer Resistance Pathway (CRP) inhibitor for the treatment of gastric, pancreatic and other cancers in combination with existing anti-cancer therapies.

For more info about Bold:

Upcoming Events

  1. NRC’s Human Health Therapeutics Programs Recharge

    November 16 @ 9:00 AM - 11:30 AM
  2. LifeSciences BC Showcase Series: Kelowna

    November 20 @ 5:30 PM - 7:30 PM
  3. LifeSciences BC Blakes Breakfast Speaking Event

    November 22 @ 7:30 AM - 10:00 AM


LifeSciences BC Member Login

About LifeSciences BC

LifeSciences BC is a non-profit, industry association which supports and represents the life science community of British Columbia through leadership, investment, advocacy and promotion of our world-class life science community.

LifeSciences BC undertakes numerous initiatives including; local, national and international partnerships helping to facilitate investment and global partnering opportunities while nurturing economic development in B.C. through the life sciences industry.


Latest Tweets